Raman in QC: System Selection and Identity Verification

Select a Raman system by demonstrating that it can support the intended identity decision on representative materials under realistic sampling conditions. A high library match, a fast demonstration or a claim of measurement through packaging is not enough. Define the materials, confusable alternatives, containers, operators and unresolved-result pathway before comparing instrument configurations.

Raman can be useful in QC, but its adoption combines instrument qualification, an appropriate analytical procedure and a controlled identification library. This GuideGxP selection framework separates those elements. It includes an original decision matrix, a library checklist and a simulated example; it does not provide a universal match threshold or a complete validation protocol for every classification algorithm.

Define the intended identity decision and its limits

Start with the decision rather than the instrument: confirmation of a labelled incoming material, comparison of a packaging component, investigation of an unexpected substance or screening of a formulated product. These tasks are not interchangeable. A procedure designed to confirm one expected identity may not be capable of identifying any unknown presented to it.

List the materials and physical forms to be covered, the likely alternatives that must be distinguished and the consequences of an incorrect decision. Define whether the sample is measured directly or through a specified container. Record the sampling location, relationship to the lot and any preparation. A spectrum collected at one point does not, by itself, establish homogeneity or the identity of every container.

Separate identity from other quality attributes. A successful identity comparison does not automatically determine assay, impurity content, microbial quality or suitability for release. The approved specification and sampling procedure decide which additional evidence remains necessary. Do not reduce a required sampling programme merely because an instrument can make a rapid measurement.

USP ⟨858⟩ describes Raman as complementary to infrared spectroscopy [3]. That scientific relationship does not make procedures interchangeable without evidence. Define an alternative analytical route for materials or presentations that Raman cannot adequately assess.

Compare configurations and sampling interfaces against requirements

A benchtop enclosure can support controlled sample presentation and laser containment. A portable device may suit measurements near receipt or storage, but introduces questions about positioning, environment, access control, data transfer and operator consistency. A probe can reach a particular interface, yet adds its own optical, cleaning and safety requirements. Compare the complete workflow rather than portability alone.

Include excitation wavelength, spectral coverage, resolution, sampling geometry, focus control and supported accessories in the requirements. There is no configuration that is automatically best for every pharmaceutical material. Demonstration samples should include the difficult combinations: the actual material, container and physical condition, not only a clean reference that produces a strong spectrum.

Ask whether the instrument retains original spectra and acquisition settings, supports controlled library deployment and allows investigation of inconclusive results. Evaluate the practical route from sample identifier to reviewed record. If data must be transferred manually, test how identifiers, versions and failed attempts remain associated; do not assume a polished pass screen proves complete traceability.

The matrix is a GuideGxP planning tool, not a procurement specification ready for signature. Each row should become a testable requirement with an owner and an acceptance rationale. Record exclusions alongside demonstrated capabilities so that an attractive demonstration does not silently broaden the authorised use.

Investigate fluorescence, heterogeneity and sample presentation

Fluorescence can obscure Raman information, while particle size, orientation, packing and focus can change the collected signal. Formulation or container contributions can also affect the spectrum. A broad background does not prove a particular impurity; weak bands do not prove absence of the expected material. Treat spectral appearance as an observation requiring context.

During the application study, separate acquisition variability from variation introduced by repositioning or taking another representative portion. Keep the acquisition and processing settings defined when making comparisons. Record exposure conditions and visible changes to the specimen. A change during repeated illumination can be evidence of an unsuitable measurement condition rather than improved identification.

Changing excitation wavelength may help some fluorescence problems but also changes the system response and application conditions. Baseline correction cannot recreate information that was never adequately measured. Do not increase power, exposure or preprocessing until a score passes without a preplanned and safe rationale. Preserve unsuccessful spectra and document why a revised acquisition is scientifically justified.

For through-container work, compare the material-plus-container result with suitable controls that answer the interference question. A blank package can help identify a contribution, but subtracting it is not automatically a validated correction. If the configuration cannot distinguish the required materials reliably, use the defined alternative route rather than treating every poor result as operator error.

Qualify the instrument independently of the classifier

Qualification should address the installed instrument and accessories in the intended configuration. Select relevant checks of Raman-shift position, spectral resolution, signal or noise, and relative intensity response where needed. Identify the reference, conditions, evaluation method and acceptance rationale for each property. An internal check may support part of the evidence without covering the entire intended use.

NIST SRM 2241 illustrates a reference specifically intended for relative-intensity correction at 785 nm excitation [4]. It is not a universal Raman-shift standard. Match each reference to its certified property and conditions, and verify its current certificate and physical condition.

Define what happens after source, detector, optics or sampling-interface work. A successful instrument check should not automatically authorise a changed library or algorithm; a successful library challenge should not excuse an unresolved optical failure. Connect the release decision to the functions affected and the evidence that remains applicable.

For instrument-to-instrument use, establish whether the spectra and decision process remain suitable on the receiving system. File compatibility alone is not method transfer evidence. Differences in response, sampling interface or processing may require additional evaluation. Keep qualification reports, configuration versions and method records linked, with a clear statement of the applications actually released.

Build and challenge the identification library

A library needs trustworthy reference identities and coverage of the intended application. Define how entries are created, reviewed, approved and retired. A larger number of spectra is not necessarily better if identities are uncertain, duplicates obscure variability or the acquisition conditions do not match routine measurements.

ICH Q2(R2) addresses independent validation samples and challenges outside identification libraries; Q14 discusses representative variation and model lifecycle [1,2]. Apply those principles through a procedure appropriate to the actual algorithm, without importing a universal numerical match threshold.

A practical library-control checklist is:

• Document reference identity and how it was established.
• Define covered materials, forms, containers and exclusions.
• Control acquisition settings and preprocessing.
• Record algorithm, parameters and library version.
• Separate development data from independent assessment data.
• Include plausible confusions and materials outside the library.
• Define acceptance, rejection and inconclusive-result handling.
• Approve updates, preserve previous versions and assess affected methods.

Simulated case — lots A and B, plus material C. Lots A and B have the same confirmed chemical identity but different particle size and packing. Lot A, resembling the library references, gives a clear accepted result. Lot B produces a lower score and more variation between positions. This is a reason to investigate representation and sampling, not to lower the acceptance threshold simply to accept B.

Material C is chemically related but outside the library. It receives the highest similarity score against the entry for A because that is the nearest available spectrum. A highest score can still be an incorrect identity. The study should test whether the complete decision procedure rejects or flags C and correctly handles the permitted variation of B, using independently established identities.

No numerical scores or experimental results are claimed in this example. Lawson and Rodriguez’s original research abstract also highlights formulation and reference-library limitations in Raman identification [5]. Their reported study performance is not evidence of universal accuracy for another instrument, material set or procedure.

Design routine records and review of uncertain results

Define the record before rollout: sample and container identity, operator, instrument configuration, acquisition settings, original spectrum, processing, library and method versions, result and review. Preserve unsuccessful or interrupted attempts when they form part of the analytical activity. A screenshot of “pass” is not a substitute for the records needed to reconstruct the decision.

Restrict routine users to authorised methods and libraries according to their roles. Separate the ability to measure from the ability to change decision criteria. Test how approved versions reach each instrument, how obsolete versions are prevented from routine use and how records remain available after software updates or network interruptions. These are selection questions as well as operating questions.

An inconclusive result needs a defined path: secure the affected material, preserve the observations, check acquisition and configuration, then investigate with appropriate expertise and an authorised analytical route. Review should address the evidence and potential impact. It should not become an undocumented human override of every inconvenient classification.

Track false acceptance, false rejection, inconclusive results and recurring acquisition problems separately. Their meaning depends on independently established identity and the evaluated population. Zero observed errors in a small demonstration does not prove zero risk. Use trends to identify whether the issue concerns instrument performance, sampling, reference coverage or the decision method.

Make the adoption decision and control subsequent changes

Before purchase or release, agree an application study with predefined questions, representative samples, challenging alternatives, records and decision responsibilities. Assess usable throughput including preparation, unsuccessful measurements, review, data handling and alternative testing. Instrument scan time alone is a poor estimate of the workload required to deliver defensible QC results.

Include laser safety in configuration selection. An enclosed system can contain a more hazardous embedded laser; normal operation and service are different conditions. Institutional laser-safety guidance emphasises protective housings, training and appropriate controls [6]. Retain safeguards and interlocks; do not open housings or aim exposed beams to resolve an analytical problem.

Assess the actual material and location for thermal, ignition, reflection and exposure hazards with the responsible safety specialist. Portable or probe operation is not inherently equivalent to a closed benchtop configuration. This article provides no power, exposure or protective-eyewear prescription: those require the specific system and hazard assessment.

Document the final decision as approved uses, excluded uses, required additional tests and unresolved limitations. Establish triggers for reassessment: new materials, suppliers or physical forms; changed containers; library or algorithm updates; maintenance; instrument replacement; and persistent inconclusive outcomes. Adoption is justified when the complete measurement-and-decision process is suitable for its defined scope, with a workable alternative when it is not.

Sources and applicability

Matrix, checklist and simulated case are original GuideGxP recommendations. ICH/FDA references are final March 2024 guidance, not universal operating limits. USP ⟨858⟩ was read through its public introduction only; full applicable compendial texts require laboratory access. Reference [5] was accessible as an abstract, not full methods. The laser manual is institutional guidance. The image is illustrative.

1. ICH / FDA. Q2(R2) Validation of Analytical Procedures. Final guidance, March 2024; sections 2.5 and 3.1.2.1.
2. ICH / FDA. Q14 Analytical Procedure Development. Final guidance, March 2024; section 8.
3. USP. ⟨858⟩ Raman Spectroscopy (2020), public introduction.
4. NIST. SRM 2241: Relative Intensity Correction Standard for Raman Spectroscopy, 785 nm Excitation. Certificate issued 7 January 2022.
5. Lawson LS, Rodriguez JD. Raman Barcode for Counterfeit Drug Product Detection. Analytical Chemistry 88 (2016), 4706–4713. doi:10.1021/acs.analchem.5b04636. Abstract.
6. University of Pennsylvania EHRS. Laser Safety Manual. Revised 29 July 2025.

Related Pharma Lab articles

• Analytical instrument qualification and USP ⟨1058⟩
• Qualification, method validation and system suitability
• FTIR qualification and performance verification